Teva Pharma (TEVA) Tops Q3 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Teva Pharma (TEVA) Tops Q3 EPS by 9c

RBC Capital Upgrades Teva Pharma (TEVA) to Outperform

November 3, 2014 8:09 AM EST

RBC Capital upgraded Teva Pharma (NYSE: TEVA) from Sector Perform to Outperform with a price target of $68.00.

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $56.47 yesterday.

... More

Teva Pharma (TEVA) Price Target Raised to $64 at Deutsche Bank

October 30, 2014 2:00 PM EDT

Deutsche Bank maintained a Buy rating on Teva Pharma (NYSE: TEVA) and raised its price target to $64.00 (from $63.00). The change follows solid Q3 results.

Analyst Gregg Gilbert said, "We updated our model following TEVAs 3Q results, which were notable for significant... More